To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TAF9TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
590 supporting clones for gene TAF9 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB067914 testis .a-u 1 to 535 2 to 536   tiling clone, to resequence, capped   535/535
(100 %)
2 diff
(99.7 %id)
CB956322 Pooled-Glandular .a-u 1257 to 2054 1 to 800   tiling clone,   800/801
(99 %)
5 diff
(99.4 %id)
BG940323 blood .a-u 1339 to 1562 1 to 224       224/224
(100 %)
0 diff
(100 %id)
AW793122 uterus .a-u 1342 to 1493 1 to 151       151/152
(99 %)
8 diff
(94.8 %id)
T30436 colon, endothelial .a-u 1343 to 1597 1 to 255       255/257
(99 %)
1 diff
(99.7 %id)
TI_1948102210   .a-u 1347 to 2111 126 to 900       775/1480
(52 %)
20 diff
(98.7 %id)
TI_1948102373   .a-u 1347 to 2131 127 to 912   fully sequenced,   786/912
(86 %)
6 diff
(99.4 %id)
TI_1948102705   .a-u 1347 to 2120 127 to 911   fully sequenced,   785/911
(86 %)
5 diff
(99.5 %id)
BT019652   .a-u 1348 to 2141 1 to 794       794/795
(99 %)
1 diff
(99.9 %id)
CV023872 mixed .a-u 1348 to 1933 1 to 586       586/586
(100 %)
0 diff
(100 %id)
TI_1948102546   .a-u 1348 to 1622 128 to 402       275/304
(90 %)
6 diff
(98.1 %id)
BG028131 Bone, osteosarcoma, cell line .a-u 1349 to 2075 1 to 724       724/994
(72 %)
17 diff
(98.3 %id)
AW793164 uterus .a-u 1354 to 1499 7 to 151       145/162
(89 %)
5 diff
(97.0 %id)
AA166707   .a-u 1364 to 1950 1 to 582     Submitted on the opposite strand 582/599
(97 %)
10 diff
(98.4 %id)
R15884 whole brain .a-u 1366 to 1731 1 to 378       378/426
(88 %)
19 diff
(95.6 %id)
H11363.
matches multiple genes
whole brain .a-u 1371 to 1871 66 to 568     also hits gene GDPD5 503/656
(76 %)
18 diff
(97.3 %id)
CA941153 Pancreas, Purified pancreatic islet .a-u 1379 to 1835 1 to 460   fully sequenced,   460/460
(100 %)
13 diff
(97.2 %id)
EH319929   .a-u 1391 to 1470 1 to 81       81/81
(100 %)
1 diff
(98.8 %id)
BU599589 mixed (pool of 40 RNAs) .a-u 1418 to 2202 1 to 792       792/792
(100 %)
14 diff
(98.3 %id)
BF878974 lung_tumor .a-u 1424 to 1826 8 to 410       403/430
(93 %)
5 diff
(98.9 %id)
BF879167 lung_tumor .a-u 1424 to 1826 8 to 410       403/430
(93 %)
5 diff
(98.9 %id)
BU934255 mixed (pool of 40 RNAs) .a-u 1424 to 2144 1 to 721       721/821
(87 %)
4 diff
(99.6 %id)
BF823265 kidney_tumor .a-u 1431 to 1626 196 to 1     Submitted on the opposite strand 196/196
(100 %)
4 diff
(98.0 %id)
TI_151798269   .a-u 1434 to 1919 99 to 589       491/756
(64 %)
43 diff
(94.4 %id)
EH337301   .a-u 1436 to 1513 1 to 78       78/78
(100 %)
0 diff
(100 %id)
BF913788 uterus_tumor .a-u 1439 to 1867 445 to 17     Submitted on the opposite strand 429/455
(94 %)
0 diff
(100 %id)
BF913792 uterus_tumor .a-u 1439 to 1895 458 to 3     Submitted on the opposite strand 456/468
(97 %)
0 diff
(100 %id)
BF913794 uterus_tumor .a-u 1439 to 1860 421 to 1     Submitted on the opposite strand 421/431
(97 %)
8 diff
(98.2 %id)
BF911618 uterus_tumor .a-u 1444 to 1867 441 to 10     Submitted on the opposite strand 432/441
(97 %)
0 diff
(100 %id)
BF911751 uterus_tumor .a-u 1444 to 1931 510 to 22     Submitted on the opposite strand 489/510
(95 %)
0 diff
(100 %id)
BF911752 uterus_tumor .a-u 1444 to 1931 509 to 24     Submitted on the opposite strand 486/509
(95 %)
0 diff
(100 %id)
BQ379539 uterus_tumor .a-u 1444 to 1818 425 to 55       371/425
(87 %)
0 diff
(100 %id)
BG768668 melanotic melanoma, high MDR (cell line), skin .a-u 1446 to 2123 1 to 679       679/679
(100 %)
10 diff
(98.6 %id)
BF911753 uterus_tumor .a-u 1447 to 1931 17 to 497       481/503
(95 %)
13 diff
(97.5 %id)
CB112296 Liver .a-u 1452 to 1860 1 to 409       409/409
(100 %)
0 diff
(100 %id)
BF911747 uterus_tumor .a-u 1456 to 1931 13 to 488       476/501
(95 %)
6 diff
(98.9 %id)
N87795   .a-u 1457 to 1604 1 to 144       144/144
(100 %)
8 diff
(94.5 %id)
BF911620 uterus_tumor .a-u 1459 to 1931 1 to 472       472/480
(98 %)
20 diff
(95.9 %id)
W04983 liver and spleen .a-u 1468 to 1845 1 to 381       381/456
(83 %)
8 diff
(98.3 %id)
BE169077 head_neck .a-u 1471 to 1719 248 to 1     Submitted on the opposite strand 248/248
(100 %)
6 diff
(97.6 %id)
BF913755 uterus_tumor .a-u 1476 to 1931 19 to 472       454/477
(95 %)
5 diff
(99.0 %id)
BG950749 colon .a-u 1479 to 1789 1 to 314       314/314
(100 %)
17 diff
(94.6 %id)
BP298639   .a-u 1499 to 2059 1 to 560       560/560
(100 %)
2 diff
(99.7 %id)
BF911749 uterus_tumor .a-u 1511 to 1931 1 to 420       420/428
(98 %)
4 diff
(99.1 %id)
N56000   .a-u 1513 to 1677 1 to 165       165/167
(98 %)
3 diff
(98.3 %id)
N24453 melanocyte .a-u 1530 to 1766 1 to 237       237/237
(100 %)
0 diff
(100 %id)
BU521711 leiomyosarcoma, uterus .a-u 1531 to 2174 1 to 645       645/845
(76 %)
7 diff
(99.2 %id)
BG117624 adenocarcinoma, cell line, Liver .a-u 1550 to 2229 1 to 677       677/943
(71 %)
7 diff
(99.3 %id)
BI002764 head_normal .a-u 1557 to 1834 25 to 297       273/297
(91 %)
6 diff
(98.0 %id)
BF918046 uterus_tumor .a-u 1566 to 1811 249 to 4     Submitted on the opposite strand 246/253
(97 %)
0 diff
(100 %id)
ES311378 frontal balding hair, skin .a-u 1566 to 1740 1 to 175       175/175
(100 %)
0 diff
(100 %id)
BF762056 colon_est .a-u 1574 to 1960 387 to 1     Submitted on the opposite strand 387/387
(100 %)
4 diff
(99.0 %id)
BG193843   .a-u 1577 to 2328 769 to 14   tiling clone, Submitted on the opposite strand 756/866
(87 %)
0 diff
(100 %id)
BF764866 colon_est .a-u 1621 to 1960 340 to 1     Submitted on the opposite strand 340/340
(100 %)
1 diff
(99.8 %id)
EC545121 Prostate .a-u 1654 to 1749 1 to 96       96/96
(100 %)
1 diff
(99.0 %id)
EC477958 Prostate .a-u 1655 to 1750 1 to 96       96/99
(96 %)
1 diff
(99.0 %id)
EC516691 Prostate .a-u 1655 to 1749 1 to 95       95/95
(100 %)
0 diff
(100 %id)
BF917501 uterus_tumor .a-u 1663 to 1833 1 to 171       171/171
(100 %)
0 diff
(100 %id)
R09330 liver and spleen .a-u 1672 to 1854 1 to 195   fully sequenced,   195/195
(100 %)
3 diff
(98.5 %id)
R97471.
matches multiple genes
liver and spleen .a-u 1672 to 2084 1 to 419     also hits gene CKS1B, CKS1BP3 419/422
(99 %)
14 diff
(96.7 %id)
AW474204 lymph node, lymphoma, follicular mixed small and largecell .a-u 1672 to 2220 561 to 12   AAA   550/619
(88 %)
19 diff
(97.0 %id)
BM263766 Pancreas, Purified pancreatic islet .a-u 1690 to 2159 1 to 469       469/469
(100 %)
7 diff
(98.6 %id)
R97425.
matches multiple genes
liver and spleen .a-u 1693 to 2076 390 to 3     also hits gene peytabu 388/392
(98 %)
0 diff
(100 %id)
AA677299 liver and spleen .a-u 1709 to 2073 370 to 6       365/370
(98 %)
0 diff
(100 %id)
AW192501 adenocarcinoma, Pancreas .a-u 1717 to 2137 421 to 1       421/421
(100 %)
23 diff
(94.6 %id)
EC526999 Prostate .a-u 1736 to 1840 1 to 105       105/114
(92 %)
3 diff
(97.4 %id)
EC539991 Prostate .a-u 1740 to 1840 1 to 98       98/108
(90 %)
6 diff
(94.5 %id)
TI_1948102706   .a-u 1741 to 2148 537 to 116   fully sequenced,   422/537
(78 %)
5 diff
(99.1 %id)
BF911744 uterus_tumor .a-u 1750 to 1931 10 to 192       183/198
(92 %)
8 diff
(96.0 %id)
EC518422 Prostate .a-u 1755 to 1840 1 to 86       86/96
(89 %)
2 diff
(98.0 %id)
EC527293 Prostate .a-u 1756 to 1840 1 to 85       85/95
(89 %)
2 diff
(97.9 %id)
AW273157 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a-u 1756 to 2074 319 to 1       319/322
(99 %)
12 diff
(96.3 %id)
AA095209   .a-u 1758 to 1980 1 to 223       223/223
(100 %)
7 diff
(96.9 %id)
AI810281 Prostate .a-u 1767 to 2215 451 to 7       445/451
(98 %)
0 diff
(100 %id)
AW072606 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .a-u 1773 to 2224 451 to 1       451/453
(99 %)
7 diff
(98.5 %id)
EC458723 Prostate .a-u 1792 to 1900 1 to 108       108/108
(100 %)
5 diff
(95.4 %id)
EC494993 Prostate .a-u 1795 to 1907 1 to 109       109/111
(98 %)
8 diff
(92.8 %id)
BQ330280 lung_tumor .a-u 1798 to 2121 1 to 325       325/325
(100 %)
4 diff
(98.8 %id)
CA866182 Pancreas, Purified pancreatic islet .a-u 1805 to 1903 99 to 1   fully sequenced,   99/99
(100 %)
11 diff
(88.9 %id)
AI024763 breast .a-u 1810 to 2089 280 to 1       280/280
(100 %)
14 diff
(95.0 %id)
AA626755 lung, lung carcinoma .a-u 1814 to 2211 1 to 398       398/398
(100 %)
1 diff
(99.8 %id)
R09219 liver and spleen .a-u 1824 to 2061 247 to 1   fully sequenced,   247/247
(100 %)
7 diff
(97.2 %id)
AW754493 colon .a-u 1836 to 1965 144 to 16       129/144
(89 %)
0 diff
(100 %id)
AW754497 colon .a-u 1836 to 1973 140 to 1       140/140
(100 %)
9 diff
(93.6 %id)
BF941000 brain, oligodendroglioma .a-u 1840 to 2089 250 to 1       250/250
(100 %)
16 diff
(93.6 %id)
BF512969   .a-u 1849 to 2214 383 to 18   AAA   366/366
(100 %)
5 diff
(98.7 %id)
TI_1948102547   .a-u 1875 to 2141 329 to 63       267/294
(90 %)
0 diff
(100 %id)
GD138383   .a-u 1883 to 2083 1 to 201       201/212
(94 %)
1 diff
(99.6 %id)
TI_1948102374   .a-u 1897 to 2148 304 to 56   fully sequenced,   249/269
(92 %)
6 diff
(97.8 %id)
AI146946 senescent fibroblast .a-u 1902 to 2089 189 to 1       189/193
(97 %)
18 diff
(90.7 %id)
Z21437   .a-u 1907 to 2128 222 to 1       222/222
(100 %)
0 diff
(100 %id)
EC559848 Prostate .a-u 1913 to 2006 1 to 94       94/94
(100 %)
3 diff
(96.9 %id)
AI362283 brain, glioblastoma (pooled) .a-u 1915 to 2089 175 to 1       175/175
(100 %)
3 diff
(98.3 %id)
DB339896 testis .a-u 1985 to 2340 358 to 1   tiling clone, to resequence,   358/358
(100 %)
3 diff
(99.2 %id)
EC492950 Prostate .a-u 2076 to 2149 13 to 86       74/86
(86 %)
6 diff
(93.1 %id)
NM_016283.4   .b 1 to 922 1 to 922 exact RefSeq, AAA   922/922
(100 %)
0 diff
(100 %id)
BG942333 blood .b 34 to 203 1 to 170   tiling clone,   170/170
(100 %)
1 diff
(99.5 %id)
AU098495   .b 41 to 340 1 to 300       300/300
(100 %)
0 diff
(100 %id)
AU102679   .b 41 to 90 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BP206495 coronary artery .b 41 to 621 1 to 582 exact     582/582
(100 %)
1 diff
(99.9 %id)
BG703479 brain, hippocampus .b 43 to 805 1 to 775 E113*     775/943
(82 %)
23 diff
(97.6 %id)
AV741335 cord Blood .b 44 to 307 32 to 287       256/287
(89 %)
16 diff
(94.5 %id)
AW955472   .b 58 to 726 1 to 664 V62A Q165P W166G     664/665
(99 %)
16 diff
(97.6 %id)
BI459809 testis .b 58 to 783 1 to 723 V14L G15E T17P T18H L19*     723/735
(98 %)
27 diff
(96.4 %id)
CN363622 embryonic stem cells, DMSO-treated H9 cellline .b 60 to 666 1 to 607 exact     607/607
(100 %)
4 diff
(99.4 %id)
BU537661 mixed (pool of 40 RNAs) .b 60 to 677 1 to 621 K168Q     621/810
(76 %)
13 diff
(98.4 %id)
AA305075 colon .b 61 to 462 1 to 402       402/402
(100 %)
1 diff
(99.8 %id)
AF151895   .b 61 to 946 1 to 886 exact tiling clone,   886/891
(99 %)
1 diff
(99.9 %id)
BU599093 mixed (pool of 40 RNAs) .b 61 to 850 1 to 797 exact     797/797
(100 %)
19 diff
(97.7 %id)
CB985757 Pooled-Glandular .b 61 to 784 1 to 732 exact     732/763
(95 %)
13 diff
(98.3 %id)
BG432384 Kidney .b 62 to 904 1 to 833 V14L G15E T17P T18H L19*     833/834
(99 %)
28 diff
(96.7 %id)
BM009636 amelanotic melanoma, cell line, skin .b 62 to 788 1 to 726 G13X L43X I75M V76L D77I ...     726/727
(99 %)
7 diff
(99.1 %id)
BM010746 amelanotic melanoma, cell line, skin .b 62 to 716 1 to 665 V14L G15E T17P T18H L19*     665/665
(100 %)
18 diff
(97.3 %id)
BM146696 leukopheresis .b 62 to 371 1 to 310       310/315
(98 %)
6 diff
(98.1 %id)
CB985356 Pooled-Glandular .b 63 to 796 1 to 734 exact     734/734
(100 %)
3 diff
(99.6 %id)
TI_59384398   .b 63 to 788 65 to 789 G13X L43X I75M V76L D77I ...     725/726
(99 %)
6 diff
(99.2 %id)
TI_59385598   .b 63 to 716 61 to 724 V14L G15E T17P T18H L19*     664/664
(100 %)
17 diff
(97.5 %id)
BM807509 amelanotic melanoma, cell line, skin .b 64 to 944 1 to 884 exact AAA   884/884
(100 %)
10 diff
(98.9 %id)
BM915623 amelanotic melanoma, cell line, skin .b 64 to 944 1 to 882 exact AAA   882/882
(100 %)
3 diff
(99.7 %id)
BG502658 embryonal carcinoma, testis .b 65 to 788 1 to 725 E164*     725/733
(98 %)
22 diff
(97.0 %id)
TI_57149990   .b 65 to 803 32 to 775 G13R     744/988
(75 %)
18 diff
(98.2 %id)
BG619296 placenta .b 67 to 741 1 to 680 L2V N112T E113*     680/792
(85 %)
18 diff
(97.8 %id)
BI763475 pooled colon, kidney, stomach .b 70 to 803 1 to 739 G13R     739/952
(77 %)
12 diff
(98.8 %id)
BI913284 brain .b 71 to 868 1 to 803 G13X     803/803
(100 %)
13 diff
(98.4 %id)
TI_57241253   .b 71 to 868 36 to 838 G13X     803/838
(95 %)
19 diff
(97.8 %id)
AJ878880 placenta .b 72 to 719 1 to 648 exact     648/648
(100 %)
0 diff
(100 %id)
AJ878881   .b 72 to 719 1 to 648 exact     648/648
(100 %)
0 diff
(100 %id)
DB457294 testis .b 72 to 538 1 to 467       467/467
(100 %)
0 diff
(100 %id)
BG495378 lung, mucoepidermoid carcinoma .b 72 to 843 1 to 779 E138A E139A I140Q V141S H142C ...     779/780
(99 %)
26 diff
(96.7 %id)
BU533662 mixed (pool of 40 RNAs) .b 72 to 822 1 to 757 exact     757/820
(92 %)
14 diff
(98.3 %id)
BM738025 Ascites, stomach .b 72 to 607 1 to 535       535/535
(100 %)
2 diff
(99.7 %id)
BC007349 Lymph, Burkitt lymphoma .b 76 to 922 1 to 847 exact available from MGC, AAA   847/847
(100 %)
0 diff
(100 %id)
BC007426 Lymph, Burkitt lymphoma .b 76 to 922 1 to 847   available from MGC, AAA   847/847
(100 %)
0 diff
(100 %id)
BF790637 muscle (skeletal) .b 76 to 734 1 to 644 V14W G15K K16N T17H L19R ...     644/818
(78 %)
31 diff
(96.3 %id)
BE737339 adenocarcinoma, Pancreas .b 77 to 734 38 to 691 V14L G15E T17P T18H L19*     654/692
(94 %)
10 diff
(98.6 %id)
CN363620 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 78 to 759 8 to 689 exact     682/689
(98 %)
6 diff
(99.2 %id)
BG941663 blood .b 80 to 194 1 to 116       116/116
(100 %)
4 diff
(96.6 %id)
AV758524 bone marrow .b 80 to 707 64 to 689 D59G     626/712
(87 %)
21 diff
(97.1 %id)
AA031331 uterus .b 81 to 574 1 to 494   fully sequenced,   494/494
(100 %)
0 diff
(100 %id)
BU941424 mixed (pool of 40 RNAs) .b 83 to 743 1 to 667 E104X L160F K161E W162M I163D ...     667/810
(82 %)
25 diff
(97.0 %id)
AV756946 bone marrow .b 85 to 698 74 to 683 D59G     610/636
(95 %)
14 diff
(97.8 %id)
BQ429454 testis .b 85 to 837 1 to 757 exact     757/758
(99 %)
8 diff
(99.0 %id)
BU952164 Pancreas, Purified pancreatic islet .b 85 to 449 1 to 366   fully sequenced,   366/366
(100 %)
3 diff
(99.2 %id)
BF132919.
matches multiple genes
lung, Lung, mucoepidermoid carcinoma, mucoepidermoid carcinoma .b 86 to 610 1 to 525   available from MGC, Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base), also hits gene LRBA 525/821
(63 %)
15 diff
(98.2 %id)
AA878870 hepatic adenoma, Liver .b 87 to 875 787 to 3 N5T I6S L7C L8S T9P ...     785/990
(79 %)
14 diff
(98.6 %id)
BQ920778 carcinoma, cell line, Prostate .b 87 to 944 1 to 870 T9P G10V T11H P12Q V14L ... tiling clone, AAA   872/870
(100 %)
18 diff
(98.0 %id)
AA446846   .b 89 to 437 1 to 346       346/346
(100 %)
6 diff
(98.3 %id)
BF105823 lung .b 90 to 770 1 to 670 L2V N33K V34C D36*     670/689
(97 %)
24 diff
(96.6 %id)
BM761913 myeloma .b 91 to 734 8 to 651 exact     644/644
(100 %)
4 diff
(99.4 %id)
TI_1948098723   .b 92 to 610 645 to 128       518/548
(94 %)
2 diff
(99.7 %id)
CV026527 mixed .b 93 to 610 1 to 518       518/604
(85 %)
2 diff
(99.7 %id)
DB446614 testis .b 93 to 519 1 to 427       427/427
(100 %)
0 diff
(100 %id)
BE561457 Burkitt lymphoma, lymph .b 95 to 806 1 to 701       701/888
(78 %)
18 diff
(98.0 %id)
AA447922   .b 96 to 595 1 to 500       500/501
(99 %)
1 diff
(99.9 %id)
BE270829 Burkitt lymphoma, lymph .b 97 to 929 1 to 819   fully sequenced, AAA   819/819
(100 %)
24 diff
(97.1 %id)
BF576620 muscle (skeletal) .b 97 to 800 1 to 702       702/881
(79 %)
26 diff
(97.1 %id)
BI601615 brain, hypothalamus .b 98 to 798 7 to 715       709/1033
(68 %)
19 diff
(98.2 %id)
BI597350 brain, hypothalamus .b 98 to 950 7 to 862       856/881
(97 %)
19 diff
(97.9 %id)
BI668833 brain, hypothalamus .b 98 to 704 7 to 612       606/612
(99 %)
2 diff
(99.7 %id)
TI_45216124   .b 98 to 950 130 to 985       856/1004
(85 %)
25 diff
(97.6 %id)
TI_45216283   .b 98 to 798 130 to 838       709/1156
(61 %)
27 diff
(97.7 %id)
TI_44345539   .b 98 to 704 132 to 737       606/737
(82 %)
9 diff
(98.8 %id)
DB493570 hypothalamus .b 100 to 609 1 to 510       510/510
(100 %)
1 diff
(99.9 %id)
BQ436010 epithelioid carcinoma, Pancreas .b 100 to 944 1 to 850       850/878
(96 %)
11 diff
(98.8 %id)
CN363621 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 108 to 593 9 to 494       486/494
(98 %)
0 diff
(100 %id)
AA026887 uterus .b 172 to 389 1 to 218       218/219
(99 %)
3 diff
(98.7 %id)
BE271012 Burkitt lymphoma, lymph .b 334 to 894 563 to 5   fully sequenced,   559/563
(99 %)
0 diff
(100 %id)
BU951907 Pancreas, Purified pancreatic islet .b 388 to 946 560 to 2   fully sequenced,   559/560
(99 %)
0 diff
(100 %id)
AA837404 germinal center B cell .b 408 to 946 546 to 8       539/555
(97 %)
0 diff
(100 %id)
AV725215 hypothalamus .b 417 to 921 69 to 574   AAA   506/574
(88 %)
6 diff
(99.0 %id)
AW196971 pooled germ cell tumors .b 417 to 946 534 to 5       530/543
(97 %)
0 diff
(100 %id)
TI_154034183   .b 419 to 944 613 to 88   AAA   526/905
(58 %)
11 diff
(98.8 %id)
AI636657 pooled germ cell tumors .b 424 to 944 521 to 1       521/521
(100 %)
0 diff
(100 %id)
AA279066 germinal center B cell .b 438 to 946 513 to 5       509/513
(99 %)
0 diff
(100 %id)
AA446847   .b 438 to 567 130 to 1       130/130
(100 %)
2 diff
(98.5 %id)
AI025283   .b 438 to 946 510 to 2       509/510
(99 %)
0 diff
(100 %id)
CA443427 Fibrosarcoma .b 439 to 944 524 to 19   AAA   506/506
(100 %)
9 diff
(98.3 %id)
AA845528 parathyroid gland, parathyroid tumor .b 459 to 944 496 to 11   AAA   486/486
(100 %)
0 diff
(100 %id)
AA936074 pooled germ cell tumors .b 464 to 944 480 to 1       480/480
(100 %)
2 diff
(99.6 %id)
CB053047 leiomyosarcoma, soft tissue .b 464 to 944 14 to 494   fully sequenced, AAA   481/494
(97 %)
6 diff
(98.8 %id)
DB564642 hypothalamus .b 478 to 942 1 to 465     Submitted on the opposite strand 465/467
(99 %)
1 diff
(99.8 %id)
BP384785 pancreatic islet .b 487 to 946 1 to 461     Submitted on the opposite strand 461/465
(99 %)
2 diff
(99.6 %id)
DB522745 testis .b 488 to 947 1 to 460     Submitted on the opposite strand 460/460
(100 %)
0 diff
(100 %id)
BF003040 Prostate .b 488 to 944 457 to 1       457/457
(100 %)
0 diff
(100 %id)
BE467269 carcinoid, lung .b 500 to 946 448 to 2       447/448
(99 %)
0 diff
(100 %id)
CB053046 leiomyosarcoma, soft tissue .b 504 to 944 464 to 24   fully sequenced, AAA   441/441
(100 %)
0 diff
(100 %id)
BQ185997 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 506 to 867 1 to 376   fully sequenced, AAA   376/376
(100 %)
9 diff
(97.7 %id)
AA568448 colon, colon tumor RER+ .b 507 to 945 439 to 1       439/439
(100 %)
0 diff
(100 %id)
AI358381 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 524 to 875 368 to 17   AAA   352/352
(100 %)
0 diff
(100 %id)
BG060181 nasopharynx, normal epithelium .b 524 to 944 435 to 18   AAA Submitted on the opposite strand 418/418
(100 %)
7 diff
(98.4 %id)
AI351514   .b 528 to 946 422 to 4       419/422
(99 %)
0 diff
(100 %id)
AL048514 uterus .b 535 to 871 1 to 337       337/365
(92 %)
1 diff
(99.8 %id)
AW470751 2 pooled tumors (clear cell type), Kidney .b 537 to 946 411 to 2       410/411
(99 %)
0 diff
(100 %id)
AA026888 uterus .b 539 to 946 415 to 6       410/415
(98 %)
0 diff
(100 %id)
BP197714 adrenal gland .b 543 to 867 1 to 325   AAA   325/325
(100 %)
0 diff
(100 %id)
AA031332 uterus .b 544 to 922 382 to 1   fully sequenced,   382/382
(100 %)
2 diff
(99.5 %id)
AA632383 breast .b 555 to 943 389 to 1       389/389
(100 %)
0 diff
(100 %id)
BP424252 small intestine .b 561 to 946 1 to 386     Submitted on the opposite strand 386/387
(99 %)
1 diff
(99.8 %id)
AA150301.
matches multiple genes
uterus .b 569 to 946 388 to 6     also hits gene TAF1_ 383/388
(98 %)
0 diff
(100 %id)
H20001 brain .b 574 to 937 1 to 364       364/364
(100 %)
0 diff
(100 %id)
AI090910 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 585 to 946 367 to 6       362/367
(98 %)
0 diff
(100 %id)
AW236006 Kidney .b 605 to 944 340 to 1       340/340
(100 %)
2 diff
(99.5 %id)
BU934358 mixed (pool of 40 RNAs) .b 631 to 944 1 to 314       314/317
(99 %)
4 diff
(98.8 %id)
AI718051 aorta .b 632 to 936 308 to 4       305/308
(99 %)
0 diff
(100 %id)
BM145557 leukopheresis .b 658 to 946 298 to 10       289/309
(93 %)
0 diff
(100 %id)
AA455061 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 692 to 944 269 to 17   AAA   253/253
(100 %)
0 diff
(100 %id)
AI337508 lung .b 702 to 945 244 to 1       244/244
(100 %)
0 diff
(100 %id)
BQ184285 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 713 to 867 185 to 17   fully sequenced, AAA   169/169
(100 %)
0 diff
(100 %id)
AI468881 lymph node, lymphoma, follicular mixed small and largecell .b 725 to 944 220 to 1       220/220
(100 %)
0 diff
(100 %id)
AI559878 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 727 to 944 218 to 1       218/218
(100 %)
0 diff
(100 %id)
AW062362 colon .b 751 to 944 1 to 194   AAA   194/194
(100 %)
3 diff
(98.5 %id)
AA743298 germinal center B cell .b 768 to 949 203 to 22   AAA   182/182
(100 %)
0 diff
(100 %id)
AA016093 eye, retina .c 1 to 361 1 to 367       367/369
(99 %)
15 diff
(96.0 %id)
AA046950 eye, retina .c 1 to 622 1 to 609   tiling clone, fully sequenced,   609/609
(100 %)
15 diff
(97.6 %id)
BX117839 eye, retina .c 2 to 692 1 to 691   tiling clone,   691/691
(100 %)
2 diff
(99.8 %id)
NM_001015891.1   .c 2 to 1160 1 to 1159 exact RefSeq, AAA   1159/1159
(100 %)
0 diff
(100 %id)
CD171997 White Matter .c 7 to 789 29 to 808       780/844
(92 %)
23 diff
(97.3 %id)
BE174136 head_neck .c 190 to 361 21 to 192       172/200
(86 %)
2 diff
(99.0 %id)
TI_1948098588   .c 352 to 848 624 to 127       498/1329
(37 %)
7 diff
(99.5 %id)
TI_1948098985   .c 352 to 848 621 to 125       497/1339
(37 %)
11 diff
(99.2 %id)
BM920549 pooled lung and spleen .c 354 to 1363 13 to 1032       1024/1100
(93 %)
48 diff
(95.7 %id)
BE879122 large cell carcinoma, undifferentiated, lung .c 361 to 1107 1 to 744       744/749
(99 %)
17 diff
(97.8 %id)
BI821130 pooled brain, lung, testis .c 365 to 1072 1 to 709       709/738
(96 %)
27 diff
(96.4 %id)
TI_57197958   .c 365 to 1072 70 to 778       709/807
(87 %)
31 diff
(96.2 %id)
BM821766 stomach .c 372 to 888 1 to 517       517/517
(100 %)
0 diff
(100 %id)
BG108624 retina, Retinal Pigment Epithelium sheets .c 373 to 586 1 to 214       214/214
(100 %)
0 diff
(100 %id)
BE076978 breast .c 374 to 710 11 to 348       338/362
(93 %)
14 diff
(96.2 %id)
BE076979 breast .c 374 to 710 12 to 349       338/366
(92 %)
15 diff
(96.0 %id)
AV712537   .c 376 to 785 10 to 419       410/431
(95 %)
19 diff
(95.6 %id)
AV728067 hypothalamus .c 394 to 1076 677 to 1     Submitted on the opposite strand 677/681
(99 %)
25 diff
(96.4 %id)
AV725538 hypothalamus .c 394 to 1051 663 to 5     Submitted on the opposite strand 659/667
(98 %)
0 diff
(100 %id)
AW935680 denis_drash .c 397 to 544 11 to 157       147/163
(90 %)
11 diff
(93.3 %id)
AA625391 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 397 to 981 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
AI476276 Kidney .c 408 to 951 558 to 16   AAA   543/543
(100 %)
4 diff
(99.3 %id)
AA148792.
matches multiple genes
uterus .c 411 to 795 1 to 386     also hits gene TAF1_ 386/386
(100 %)
6 diff
(98.5 %id)
AA026657 uterus .c 412 to 878 1 to 468       468/468
(100 %)
1 diff
(99.8 %id)
BQ015047 Chondrosarcoma, Left Pubic Bone .c 416 to 1182 782 to 19   tiling clone, AAA   764/764
(100 %)
3 diff
(99.7 %id)
BU622298 Cell Line, Chondrosarcoma .c 421 to 1182 778 to 19   AAA   760/760
(100 %)
3 diff
(99.7 %id)
BQ008630 Chondrosarcoma, Left Pubic Bone .c 446 to 1105 676 to 17   AAA   660/660
(100 %)
0 diff
(100 %id)
TI_149283158   .c 450 to 1182 794 to 58   AAA   737/805
(91 %)
16 diff
(98.1 %id)
BG941521 blood .c 456 to 624 1 to 169       169/169
(100 %)
1 diff
(99.5 %id)
BG942858 blood .c 456 to 687 1 to 232       232/232
(100 %)
0 diff
(100 %id)
EC488761 Prostate .c 460 to 553 6 to 98       93/98
(94 %)
6 diff
(93.9 %id)
BG055177 Prostate .c 464 to 1182 717 to 1       717/718
(99 %)
4 diff
(99.5 %id)
BM997978 lung, Metastatic Chondrosarcoma .c 499 to 1182 703 to 19   AAA   685/685
(100 %)
2 diff
(99.8 %id)
AV729600 hypothalamus .c 534 to 1160 31 to 653   AAA   623/653
(95 %)
14 diff
(97.9 %id)
AW149768 brain, medulloblastoma .c 535 to 838 304 to 1       304/304
(100 %)
9 diff
(97.1 %id)
AW169122 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 544 to 1182 639 to 1       639/639
(100 %)
2 diff
(99.7 %id)
CB854336 lung, Primary Lung Epithelial Cells .c 567 to 1182 635 to 19   AAA   617/617
(100 %)
4 diff
(99.4 %id)
AI796276 Kidney .c 574 to 1182 609 to 1       609/609
(100 %)
1 diff
(99.9 %id)
TI_149275683   .c 576 to 1182 698 to 91   AAA   608/972
(62 %)
1 diff
(99.9 %id)
BU676745 lung, Primary Lung Epithelial Cells .c 576 to 1182 626 to 19   AAA   608/623
(97 %)
1 diff
(99.9 %id)
AA090696   .c 577 to 954 1 to 366       366/376
(97 %)
18 diff
(95.3 %id)
AA603456 normal prostate, Prostate .c 583 to 1182 600 to 1       600/600
(100 %)
0 diff
(100 %id)
AI566470 adenocarcinoma, Pancreas .c 586 to 1183 597 to 1       597/597
(100 %)
5 diff
(99.2 %id)
BF663369 B-cells, primary B-cells from tonsils (cell line) .c 600 to 1160 1 to 560   AAA   560/560
(100 %)
4 diff
(99.3 %id)
BF976224 B-cells, primary B-cells from tonsils (cell line) .c 600 to 1160 1 to 560   AAA   560/560
(100 %)
2 diff
(99.7 %id)
AA046476 eye, retina .c 604 to 1186 573 to 3   fully sequenced,   571/573
(99 %)
11 diff
(98.1 %id)
BE379318 endometrium, adenocarcinoma cell line, uterus .c 604 to 1133 24 to 560       543/561
(96 %)
8 diff
(98.6 %id)
AA455761 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 614 to 840 1 to 227       227/227
(100 %)
0 diff
(100 %id)
BF447152 Prostate .c 622 to 1182 561 to 1       561/561
(100 %)
3 diff
(99.5 %id)
BQ682840 melanotic melanoma, cell line, skin .c 622 to 1160 14 to 552   AAA   539/552
(97 %)
6 diff
(99.0 %id)
BQ682060 melanotic melanoma, cell line, skin .c 623 to 1160 1 to 538   AAA   538/538
(100 %)
3 diff
(99.5 %id)
BF059491 pooled germ cell tumors .c 637 to 1182 546 to 1       546/546
(100 %)
1 diff
(99.9 %id)
AA015966 eye, retina .c 741 to 1186 453 to 1       453/458
(98 %)
9 diff
(98.1 %id)
CN264781 embryonic stem cells, cell lines H1, H7, andH9 .c 806 to 911 1 to 106       106/106
(100 %)
0 diff
(100 %id)
EC526833 Prostate .c 843 to 942 1 to 99       99/99
(100 %)
1 diff
(99.0 %id)
AI718668 aorta .c 1157 to 1446 290 to 1   tiling clone,   290/290
(100 %)
7 diff
(97.6 %id)
CA422219 Bone, Enchondroma cell line .c 1217 to 1925 725 to 19   tiling clone, AAA   707/707
(100 %)
3 diff
(99.6 %id)
BI523307 brain .c 1231 to 1850 646 to 8       639/1043
(61 %)
0 diff
(100 %id)
TI_44185267   .c 1231 to 1850 646 to 8       639/1043
(61 %)
0 diff
(100 %id)
TI_57173834   .d 1 to 767 26 to 792 S2I A29R G32W G33R R35V ... tiling clone,   767/792
(96 %)
10 diff
(98.8 %id)
BI825989 brain, medulla .d 7 to 767 1 to 761       761/761
(100 %)
5 diff
(99.4 %id)
DB453905 testis .d 62 to 555 1 to 494   tiling clone,   494/494
(100 %)
2 diff
(99.6 %id)
CN273884 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 90 to 657 9 to 576       568/576
(98 %)
6 diff
(99.0 %id)
BM478302 eye, retinoblastoma .d 115 to 1041 1 to 937   tiling clone,   937/1114
(84 %)
30 diff
(97.4 %id)
TI_45215233   .e 1 to 587 121 to 706       586/706
(83 %)
6 diff
(99.2 %id)
BI597262 brain, hypothalamus .e 2 to 587 1 to 585   tiling clone,   585/585
(100 %)
6 diff
(99.0 %id)
BM479518 eye, retinoblastoma .e 150 to 626 1 to 481 Y44A D45M E46M E47K Y48S ... tiling clone,   481/567
(84 %)
11 diff
(98.1 %id)
CR986850 T-Lymphocytes .f 1 to 431 1 to 431   tiling clone,   431/431
(100 %)
0 diff
(100 %id)
BP371415 testis .f 128 to 709 1 to 581 exact tiling clone,   581/581
(100 %)
2 diff
(99.7 %id)
DB469774 hippocampus .f 150 to 586 1 to 437 exact     437/437
(100 %)
0 diff
(100 %id)
BP209985 cerebellum .g 1 to 582 1 to 582 G22E tiling clone,   582/582
(100 %)
1 diff
(99.9 %id)
CN273879 embryonic stem cells, cell lines H1, H7, andH9 .g 22 to 701 6 to 686   tiling clone,   681/686
(99 %)
6 diff
(99.2 %id)
BG490028 large cell carcinoma, lung .h 1 to 811 1 to 836 exact tiling clone,   836/856
(97 %)
51 diff
(94.1 %id)
BE885497 leiomyosarcoma, uterus .h 61 to 742 1 to 684 V14L G15E T17P T18H L19*     684/687
(99 %)
10 diff
(98.6 %id)
NM_003187.4   .h 61 to 1284 1 to 1224 exact RefSeq, AAA   1224/1224
(100 %)
0 diff
(100 %id)
BG568148 Liver .h 102 to 937 1 to 830 V14L G15E T17P T18H L19*     830/832
(99 %)
17 diff
(98.0 %id)
BM787669 stomach .h 102 to 725 1 to 624 exact     624/624
(100 %)
0 diff
(100 %id)
AI879232 brain, frontal lobe .h 104 to 622 1 to 518 exact     518/518
(100 %)
1 diff
(99.9 %id)
BP319736 pericardium .h 104 to 685 1 to 582 exact     582/582
(100 %)
0 diff
(100 %id)
BG027210 Bone, osteosarcoma, cell line .h 105 to 814 1 to 706 V14L G15E T17P T18H L19*     706/1103
(64 %)
28 diff
(97.5 %id)
CD696594 normal nasopharynx .h 111 to 809 31 to 729 exact     699/729
(95 %)
9 diff
(98.8 %id)
BU193943 melanotic melanoma, skin .h 114 to 653 1 to 549 G15R T17N T18H L19T G20R ...     549/1023
(53 %)
25 diff
(97.6 %id)
BM551152 duodenal adenocarcinoma, cell line, small intestine .h 115 to 979 1 to 878 exact     878/1120
(78 %)
23 diff
(98.0 %id)
DR158361 human embryonic stem cells differentiated toan early endodermal cell type .h 116 to 1004 1 to 889 G13R     889/889
(100 %)
6 diff
(99.4 %id)
CB159002 Liver .h 116 to 622 1 to 507 exact     507/507
(100 %)
1 diff
(99.9 %id)
AA403246   .h 117 to 599 1 to 482 exact     482/482
(100 %)
2 diff
(99.6 %id)
BM458021 leiomyosarcoma, uterus .h 117 to 980 36 to 908 exact     873/1066
(81 %)
37 diff
(96.6 %id)
BF686036 leiomyosarcoma cell line, uterus .h 120 to 912 1 to 803 V14L G15E T17P T18H L19*     779/858
(90 %)
36 diff
(95.9 %id)
H90077 liver and spleen .h 121 to 514 1 to 395 exact     395/400
(98 %)
12 diff
(97.0 %id)
T30865 breast .h 121 to 468 1 to 348 exact     348/348
(100 %)
7 diff
(98.0 %id)
N40879 placenta .h 122 to 323 1 to 205 exact     205/205
(100 %)
5 diff
(97.6 %id)
BG400717 Kidney .h 122 to 835 1 to 717 exact     717/717
(100 %)
9 diff
(98.8 %id)
BU660738 blood .h 123 to 613 9 to 499 exact     491/499
(98 %)
6 diff
(98.8 %id)
DW421170 Liver .h 123 to 403 18 to 298 exact     281/298
(94 %)
9 diff
(97.0 %id)
BP304521   .h 123 to 705 1 to 582 exact     582/582
(100 %)
3 diff
(99.5 %id)
AV739228 cord Blood .h 124 to 628 35 to 524 exact     490/524
(93 %)
16 diff
(97.0 %id)
BM467782 leiomyosarcoma, uterus .h 124 to 1200 30 to 1103 exact     1074/1149
(93 %)
35 diff
(97.0 %id)
BI257618 cervical carcinoma cell line, cervix .h 125 to 994 1 to 884 G13R     884/926
(95 %)
34 diff
(96.4 %id)
CN273888 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 126 to 884 1 to 759 exact     759/759
(100 %)
0 diff
(100 %id)
BM904642 leiomyosarcoma, uterus .h 127 to 1146 1 to 1019 exact     1019/1020
(99 %)
25 diff
(97.6 %id)
BU663051 blood .h 128 to 687 5 to 564 exact     560/564
(99 %)
8 diff
(98.6 %id)
CR610818 T cells (Jurkat cell line) Cot10-normalized .h 129 to 1283 1 to 1155 exact     1155/1155
(100 %)
0 diff
(100 %id)
BX362312   .h 129 to 608 1 to 481 exact fully sequenced,   481/481
(100 %)
2 diff
(99.6 %id)
BU940728 mixed (pool of 40 RNAs) .h 129 to 875 1 to 750 exact     750/752
(99 %)
8 diff
(99.0 %id)
BG576534 breast, mammary adenocarcinoma, cell line .h 131 to 823 40 to 754 V14L G15E T17P T18H L19*     715/754
(94 %)
71 diff
(90.6 %id)
BF980450 duodenal adenocarcinoma, cell line, small intestine .h 132 to 913 1 to 779 V14L G15E T17P T18H L19*     779/889
(87 %)
23 diff
(97.5 %id)
TI_43960952   .h 132 to 827 55 to 757 V14L G15E T17P T18H L19*     703/909
(77 %)
22 diff
(97.6 %id)
BC003400 Placenta, choriocarcinoma .h 133 to 1284 1 to 1152 exact available from MGC, AAA   1152/1152
(100 %)
1 diff
(100.0 %id)
AA188287   .h 133 to 567 1 to 444 exact     444/444
(100 %)
13 diff
(97.1 %id)
BM755670 stomach .h 133 to 567 1 to 436 V14G G15W T17N T18H L19T ...     436/436
(100 %)
2 diff
(99.6 %id)
BF308327 muscle, rhabdomyosarcoma .h 134 to 896 1 to 743 V14L G15E T17P T18H L19*     743/906
(82 %)
27 diff
(97.1 %id)
BI490053 pooled brain, lung, testis .h 135 to 957 1 to 841 V14L G15E T17P T18H L19*     841/852
(98 %)
22 diff
(97.5 %id)
BU934261 mixed (pool of 40 RNAs) .h 135 to 839 1 to 724 exact     724/850
(85 %)
28 diff
(96.8 %id)
BU959526 mixed (pool of 40 RNAs) .h 135 to 890 1 to 761 exact     761/770
(98 %)
14 diff
(98.2 %id)
AA321648 lymphoid .h 136 to 379 1 to 244 exact     244/244
(100 %)
0 diff
(100 %id)
CN273885 embryonic stem cells, cell lines H1, H7, andH9 .h 136 to 473 1 to 338 G13W     338/338
(100 %)
1 diff
(99.8 %id)
CN273886 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 136 to 798 1 to 663 exact     663/663
(100 %)
2 diff
(99.7 %id)
AA256024 germinal center B cell .h 137 to 557 8 to 429 L8H T9H G10R T11Y P12T ...     422/429
(98 %)
6 diff
(98.7 %id)
BF977250 melanotic melanoma, high MDR, skin .h 137 to 887 1 to 747 L2V     747/749
(99 %)
36 diff
(95.2 %id)
BU662769 blood .h 138 to 823 9 to 693 exact     685/693
(98 %)
6 diff
(99.2 %id)
CD676929 eye, Trabecular meshwork .h 138 to 768 1 to 631 exact     631/631
(100 %)
0 diff
(100 %id)
BU173138 eye, retinoblastoma .h 138 to 1063 42 to 972 I32M N33R V34G     931/983
(94 %)
40 diff
(96.0 %id)
BU942226 mixed (pool of 40 RNAs) .h 138 to 785 1 to 656 exact     656/667
(98 %)
23 diff
(96.6 %id)
BU656310 blood .h 140 to 614 9 to 483 K16N T17S     475/483
(98 %)
8 diff
(98.4 %id)
BF791326 muscle (skeletal) .h 140 to 938 1 to 798 L2V V14L G15E T17P T18H ...     798/853
(93 %)
13 diff
(98.5 %id)
BI544674 brain, hippocampus .h 140 to 1027 1 to 892 V14L G15E T17P T18H L19*     892/895
(99 %)
21 diff
(97.7 %id)
BG615610 embryonal carcinoma, testis .h 141 to 839 1 to 699 V14L G15E T17P T18H L19*     699/699
(100 %)
7 diff
(99.0 %id)
TI_44001083   .h 141 to 1027 80 to 970 V14L G15E T17P T18H L19*     891/973
(91 %)
25 diff
(97.5 %id)
BG573227 placenta .h 142 to 802 1 to 659 V14L G15E T17P T18H L19*     659/659
(100 %)
4 diff
(99.4 %id)
AV740754 cord Blood .h 143 to 680 44 to 562 S25P     519/592
(87 %)
16 diff
(97.3 %id)
BF576903 muscle (skeletal) .h 144 to 756 1 to 618 exact AAA   618/881
(70 %)
15 diff
(98.3 %id)
U21858   .h 144 to 1286 1 to 1143 exact tiling clone,   1143/1143
(100 %)
1 diff
(100.0 %id)
BF669242 brain, primitive neuroectoderm .h 145 to 773 1 to 631 exact     631/890
(70 %)
37 diff
(95.9 %id)
BG527290 lung, mucoepidermoid carcinoma .h 145 to 969 1 to 830 exact     830/834
(99 %)
22 diff
(97.4 %id)
AV690712 hepatocellular carcinoma .h 148 to 807 1 to 655 exact     655/657
(99 %)
31 diff
(95.3 %id)
AV691835 hepatocellular carcinoma .h 148 to 753 1 to 601 G13W     601/612
(98 %)
17 diff
(97.3 %id)
AV695133 hepatocellular carcinoma .h 148 to 793 1 to 641 G13W     641/654
(98 %)
27 diff
(95.9 %id)
AV694963 hepatocellular carcinoma .h 148 to 691 1 to 540 exact     540/611
(88 %)
5 diff
(99.2 %id)
BI093609 cervix .h 148 to 971 1 to 830 G13X     830/951
(87 %)
14 diff
(98.6 %id)
CD709300 normal nasopharynx .h 150 to 332 1 to 185 G13V V14C G15W T17N T18H ...     185/185
(100 %)
4 diff
(97.9 %id)
BG023808 duodenal adenocarcinoma, cell line, small intestine .h 151 to 980 1 to 828 V14L G15E T17P T18H L19*     828/1143
(72 %)
29 diff
(97.5 %id)
BU662182 blood .h 152 to 743 1 to 592 L2G     592/592
(100 %)
4 diff
(99.4 %id)
BF693534 muscle (skeletal) .h 152 to 654 1 to 508 V14W G15E T17P T18H L19*     508/626
(81 %)
21 diff
(96.7 %id)
BF983076 duodenal adenocarcinoma, cell line, small intestine .h 152 to 898 1 to 758 exact     758/779
(97 %)
33 diff
(95.8 %id)
BI545208 brain, hippocampus .h 152 to 993 1 to 856 L2G V14L G15E T17P T18H ...     856/856
(100 %)
37 diff
(95.7 %id)
BU175117 eye, retinoblastoma .h 152 to 980 1 to 833 G20C     833/834
(99 %)
13 diff
(98.5 %id)
CN273892 embryonic stem cells, DMSO-treated H9 cellline .h 155 to 726 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
N78226 liver and spleen .h 155 to 575 1 to 429       429/429
(100 %)
17 diff
(96.1 %id)
AA128964   .h 155 to 466 1 to 321       321/334
(96 %)
12 diff
(96.5 %id)
BE538269 cervix .h 155 to 918 1 to 763       763/820
(93 %)
24 diff
(97.1 %id)
BU945637 mixed (pool of 40 RNAs) .h 155 to 877 1 to 732       732/836
(87 %)
27 diff
(96.8 %id)
CB957721 Pooled-Glandular .h 155 to 785 1 to 636       636/792
(80 %)
11 diff
(98.7 %id)
CF597052 ovary .h 155 to 645 1 to 500       500/1299
(38 %)
27 diff
(98.0 %id)
BM745233 stomach .h 155 to 730 1 to 576       576/576
(100 %)
4 diff
(99.4 %id)
BM832752 stomach .h 155 to 682 1 to 528       528/528
(100 %)
0 diff
(100 %id)
BF672123 muscle (skeletal) .h 157 to 882 1 to 740       740/926
(79 %)
55 diff
(94.1 %id)
BG494736 lung, mucoepidermoid carcinoma .h 157 to 749 1 to 593       593/834
(71 %)
21 diff
(97.5 %id)
BG819044 anaplastic oligodendroglioma with 1p/19qloss, brain .h 157 to 979 1 to 822       822/822
(100 %)
3 diff
(99.7 %id)
BP322805 Pancreas .h 157 to 727 1 to 572       572/583
(98 %)
30 diff
(94.9 %id)
BF239451 bone marrow, from chronic myelogenous leukemia .h 158 to 788 1 to 635       635/636
(99 %)
23 diff
(96.4 %id)
TI_44165284   .h 158 to 993 122 to 971       850/971
(87 %)
38 diff
(96.1 %id)
BG164482 hypernephroma, cell line, Kidney .h 159 to 968 1 to 799       799/846
(94 %)
20 diff
(97.7 %id)
BM464494 leiomyosarcoma, uterus .h 159 to 1113 1 to 966       966/1116
(86 %)
20 diff
(98.3 %id)
H78109 liver and spleen .h 161 to 637 1 to 493       493/495
(99 %)
26 diff
(94.8 %id)
H37884 liver and spleen .h 162 to 712 1 to 567       567/572
(99 %)
28 diff
(95.2 %id)
BF105118 Kidney .h 162 to 845 1 to 683       683/850
(80 %)
22 diff
(97.5 %id)
BM470077 lymph, lymphoma, cell line .h 162 to 1106 1 to 947       947/1006
(94 %)
18 diff
(98.3 %id)
BF572123 melanotic melanoma, high MDR, skin .h 164 to 809 1 to 642       642/644
(99 %)
17 diff
(97.4 %id)
CB157872 Liver .h 168 to 316 1 to 149       149/149
(100 %)
0 diff
(100 %id)
T36197 thyroid gland .h 168 to 430 1 to 263       263/263
(100 %)
0 diff
(100 %id)
BM800271 leiomyosarcoma, uterus .h 171 to 827 1 to 673       673/900
(74 %)
29 diff
(96.8 %id)
BP429897   .h 171 to 571 4 to 404       401/404
(99 %)
1 diff
(99.8 %id)
BE567632 bladder, carcinoma, cell line .h 173 to 786 1 to 620       620/723
(85 %)
26 diff
(96.5 %id)
AA030022 uterus .h 214 to 659 1 to 446       446/446
(100 %)
0 diff
(100 %id)
N99383 liver and spleen .h 228 to 607 1 to 392       392/403
(97 %)
12 diff
(97.1 %id)
U25112   .h 245 to 1285 1 to 1041       1041/1041
(100 %)
1 diff
(100.0 %id)
U30504 brain .h 245 to 1284 1 to 1040       1040/1040
(100 %)
0 diff
(100 %id)
BX374024   .h 578 to 1283 709 to 1   fully sequenced,   709/709
(100 %)
5 diff
(99.3 %id)
N59765 liver and spleen .h 805 to 1284 486 to 1       486/487
(99 %)
13 diff
(97.4 %id)
AA029766 uterus .h 809 to 1284 478 to 1       478/478
(100 %)
2 diff
(99.6 %id)
AI879614 brain, frontal lobe .h 818 to 1285 474 to 7       468/474
(98 %)
0 diff
(100 %id)
N71430 liver and spleen .h 840 to 1285 453 to 4       450/456
(98 %)
0 diff
(100 %id)
AA186668   .h 843 to 1284 442 to 1       442/442
(100 %)
0 diff
(100 %id)
AA255929 germinal center B cell .h 867 to 1284 418 to 1       418/418
(100 %)
0 diff
(100 %id)
H89986 liver and spleen .h 882 to 1279 405 to 1       405/407
(99 %)
13 diff
(96.9 %id)
H78110 liver and spleen .h 929 to 1279 359 to 1       359/361
(99 %)
11 diff
(97.0 %id)
H37830 liver and spleen .h 936 to 1283 358 to 2       357/367
(97 %)
0 diff
(100 %id)
N30090 placenta .h 948 to 1283 343 to 6       338/352
(96 %)
0 diff
(100 %id)
AA128965   .h 1084 to 1284 235 to 35   AAA   201/201
(100 %)
0 diff
(100 %id)
GD141934   .h 1150 to 1285 1 to 137       137/150
(91 %)
2 diff
(98.7 %id)
EC499455 Prostate .h 1168 to 1285 120 to 4       117/120
(97 %)
0 diff
(100 %id)
NM_001015892.1   .i 1 to 1461 1 to 1461 exact RefSeq, AAA   1461/1461
(100 %)
0 diff
(100 %id)
TI_151771530   .i 128 to 782 101 to 762 K18X tiling clone,   662/1017
(65 %)
30 diff
(97.1 %id)
CX784292 human embryonic stem cells .i 199 to 842 1 to 644 exact     644/644
(100 %)
0 diff
(100 %id)
BE909376 epithelioid carcinoma, Pancreas .i 218 to 944 1 to 724 exact     724/988
(73 %)
22 diff
(97.8 %id)
BE910029 epithelioid carcinoma, Pancreas .i 224 to 807 1 to 582 V11L G12E T14P T15H L16*     582/582
(100 %)
2 diff
(99.7 %id)
BG720149 testis .i 258 to 954 1 to 697 exact     697/697
(100 %)
6 diff
(99.2 %id)
BP308970 brain .i 311 to 891 1 to 581 exact     581/581
(100 %)
0 diff
(100 %id)
AA308443 colon .i 314 to 889 1 to 576 exact     576/576
(100 %)
2 diff
(99.7 %id)
AW954707   .i 315 to 955 1 to 640 exact     640/641
(99 %)
9 diff
(98.6 %id)
BF175113 blood .i 351 to 559 3 to 213       211/213
(99 %)
16 diff
(92.5 %id)
BE882192 leiomyosarcoma, uterus .i 354 to 1100 1 to 740       740/740
(100 %)
15 diff
(98.0 %id)
BF725982 eye, Iris .i 358 to 799 6 to 447       447/447
(100 %)
0 diff
(100 %id)
CB145774 Liver .i 358 to 936 1 to 578       578/578
(100 %)
4 diff
(99.4 %id)
T34451 lung .i 358 to 617 1 to 261       261/261
(100 %)
1 diff
(99.7 %id)
T34431 lung .i 359 to 611 1 to 253       253/253
(100 %)
0 diff
(100 %id)
BM805536 brain, hippocampus .i 360 to 1253 21 to 919   tiling clone,   899/1083
(83 %)
35 diff
(96.8 %id)
W51863 senescent fibroblast .i 363 to 828 1 to 467       467/467
(100 %)
1 diff
(99.8 %id)
AW605237 denis_drash .i 366 to 552 187 to 1       187/215
(86 %)
1 diff
(99.6 %id)
BG164276 hypernephroma, cell line, Kidney .i 366 to 1143 1 to 765   tiling clone,   765/937
(81 %)
28 diff
(97.1 %id)
CN273887 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 370 to 1060 1 to 691       691/691
(100 %)
3 diff
(99.6 %id)
BE890012 leiomyosarcoma, uterus .i 371 to 1100 1 to 720       720/816
(88 %)
36 diff
(95.6 %id)
BQ434615 melanotic melanoma, skin .i 377 to 1268 1 to 894   tiling clone,   894/894
(100 %)
13 diff
(98.6 %id)
BF762958 colon_est .i 380 to 858 1 to 479       479/479
(100 %)
8 diff
(98.4 %id)
AA877372 2 pooled tumors (clear cell type), Kidney .i 381 to 573 193 to 1       193/193
(100 %)
0 diff
(100 %id)
BE780571 eye, retinoblastoma .i 386 to 1089 1 to 698       698/699
(99 %)
9 diff
(98.8 %id)
CN273883 embryonic stem cells, DMSO-treated H9 cellline .i 388 to 967 1 to 580       580/580
(100 %)
0 diff
(100 %id)
EC491968 Prostate .i 389 to 486 1 to 97       97/97
(100 %)
6 diff
(93.9 %id)
CN273881 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 393 to 871 1 to 476       476/476
(100 %)
3 diff
(99.4 %id)
H27053 breast .i 394 to 798 1 to 405       405/410
(98 %)
2 diff
(99.6 %id)
BE870774 adenocarcinoma, colon .i 394 to 1149 1 to 766       766/768
(99 %)
35 diff
(95.5 %id)
BU509526 leiomyosarcoma, uterus .i 397 to 1246 1 to 861   tiling clone,   861/942
(91 %)
27 diff
(97.2 %id)
AW795858 uterus .i 407 to 815 10 to 417       408/417
(97 %)
7 diff
(98.4 %id)
AW795863 uterus .i 408 to 815 1 to 409       409/409
(100 %)
6 diff
(98.6 %id)
AW795864 uterus .i 413 to 815 403 to 1       403/403
(100 %)
4 diff
(99.1 %id)
T08172   .i 422 to 779 1 to 358       358/358
(100 %)
0 diff
(100 %id)
CN273882 embryonic stem cells, cell lines H1, H7, andH9 .i 428 to 1159 1 to 731   tiling clone,   731/731
(100 %)
3 diff
(99.6 %id)
FN049136 breast carcinoma .i 428 to 515 88 to 1     Submitted on the opposite strand 88/88
(100 %)
0 diff
(100 %id)
BF986381 placenta_normal .i 430 to 913 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
BM822691 stomach .i 430 to 737 1 to 308       308/308
(100 %)
1 diff
(99.7 %id)
BM831200 stomach .i 430 to 1010 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BM831409 stomach .i 430 to 1047 1 to 618       618/618
(100 %)
2 diff
(99.7 %id)
BM831457 stomach .i 430 to 980 1 to 551       551/551
(100 %)
0 diff
(100 %id)
CR606803 T cells (Jurkat cell line) Cot10-normalized .j 1 to 1711 4 to 1714 exact tiling clone,   1714/1714
(100 %)
0 diff
(100 %id)
AL558864 T cells from T cell leukemia .j 1 to 880 4 to 880       880/880
(100 %)
9 diff
(99.0 %id)
TI_57220247   .j 8 to 824 25 to 840       816/841
(97 %)
13 diff
(98.5 %id)
BI756401 brain .j 22 to 824 1 to 802       802/803
(99 %)
7 diff
(99.2 %id)
BF244599 brain, glioblastoma .j 249 to 912 1 to 662       662/880
(75 %)
21 diff
(97.7 %id)
CN273891 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 295 to 919 1 to 625       625/625
(100 %)
5 diff
(99.2 %id)
CN273878 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 356 to 930 1 to 574       574/574
(100 %)
2 diff
(99.7 %id)
BF175631 blood .j 419 to 772 1 to 354       354/354
(100 %)
4 diff
(98.9 %id)
W49568 senescent fibroblast .j 787 to 978 1 to 193       193/193
(100 %)
1 diff
(99.5 %id)
BM685999 eye, Retina Foveal and Macular .j 794 to 1290 1 to 497   fully sequenced,   497/497
(100 %)
5 diff
(99.0 %id)
BM803829 leiomyosarcoma, uterus .j 809 to 1750 12 to 964       953/1001
(95 %)
5 diff
(99.6 %id)
AL580590 T cells from T cell leukemia .j 818 to 1711 895 to 1       895/895
(100 %)
9 diff
(99.0 %id)
TI_159714630   .j 850 to 1742 964 to 83   AAA   882/1022
(86 %)
20 diff
(98.1 %id)
TI_154044950   .j 857 to 1742 952 to 82   AAA   871/997
(87 %)
19 diff
(98.1 %id)
W01605 liver and spleen .j 870 to 1231 1 to 369       369/373
(98 %)
12 diff
(96.8 %id)
H81642 eye, retina .j 891 to 1338 1 to 457       457/459
(99 %)
15 diff
(96.8 %id)
TI_154062703   .j 905 to 1742 923 to 93   AAA   831/985
(84 %)
16 diff
(98.4 %id)
AI609267 normal gingiva (cell line from primarykeratinocytes) .j 913 to 1742 821 to 1       821/825
(99 %)
25 diff
(97.0 %id)
BU570448 testis .j 915 to 1697 1 to 782       782/790
(98 %)
10 diff
(98.8 %id)
TI_149293703   .j 923 to 1742 890 to 82   AAA   809/939
(86 %)
15 diff
(98.5 %id)
BI490874 pooled brain, lung, testis .j 929 to 1663 740 to 1       740/1076
(68 %)
11 diff
(99.0 %id)
TI_43960954   .j 929 to 1663 740 to 1       740/1076
(68 %)
11 diff
(99.0 %id)
BU620877 Cell Line, Chondrosarcoma .j 947 to 1742 811 to 19   AAA   793/793
(100 %)
6 diff
(99.3 %id)
CA306838 Alveolar Macrophage, lung .j 947 to 1742 813 to 19   AAA   795/795
(100 %)
6 diff
(99.3 %id)
BU595109 mixed (pool of 40 RNAs) .j 950 to 1731 1 to 782       782/858
(91 %)
43 diff
(95.0 %id)
AI609002 normal gingiva (cell line from primarykeratinocytes) .j 966 to 1742 779 to 1       779/780
(99 %)
16 diff
(98.0 %id)
AI934506 anaplastic oligodendroglioma, brain .j 998 to 1743 751 to 9       743/751
(98 %)
0 diff
(100 %id)
TI_57176036   .j 1006 to 1741 58 to 794   AAA   737/794
(92 %)
6 diff
(99.3 %id)
AI765146 colon, colon tumor, RER+ .j 1010 to 1736 732 to 6       727/732
(99 %)
0 diff
(100 %id)
CA309963 Alveolar Macrophage, lung .j 1011 to 1742 749 to 19   AAA   731/731
(100 %)
3 diff
(99.6 %id)
BI829299 brain, medulla .j 1014 to 1741 1 to 728   AAA   728/728
(100 %)
2 diff
(99.8 %id)
BQ772517 Chondrosarcoma Cell line .j 1015 to 1742 747 to 19   AAA   729/731
(99 %)
6 diff
(99.2 %id)
BM975238 lung .j 1020 to 1742 741 to 19   AAA   723/727
(99 %)
3 diff
(99.6 %id)
TI_154126111   .j 1021 to 1742 798 to 78   AAA   721/919
(78 %)
5 diff
(99.5 %id)
H94147 liver and spleen .j 1023 to 1360 1 to 338   fully sequenced,   338/338
(100 %)
21 diff
(93.8 %id)
BU608283 Human Lung Epithelial cells, lung .j 1024 to 1742 737 to 19   AAA   719/719
(100 %)
0 diff
(100 %id)
N45338 liver and spleen .j 1026 to 1218 1 to 194       194/194
(100 %)
1 diff
(99.5 %id)
CA416346 Chondrosarcoma Cell line .j 1026 to 1742 733 to 19   AAA   715/716
(99 %)
4 diff
(99.5 %id)
CA421215 Bone, Enchondroma cell line .j 1035 to 1742 726 to 19   AAA   708/708
(100 %)
0 diff
(100 %id)
CN273890 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 1038 to 1686 9 to 657       649/657
(98 %)
6 diff
(99.1 %id)
AI872127 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .j 1039 to 1743 707 to 2       706/709
(99 %)
0 diff
(100 %id)
BM671176 eye, optic nerve .j 1041 to 1742 720 to 19   AAA   702/702
(100 %)
0 diff
(100 %id)
CN478625 Human Lung Epithelial cells, lung .j 1043 to 1742 718 to 19   AAA   700/700
(100 %)
0 diff
(100 %id)
CA411859 Chondrosarcoma Grade II, Left Pelvis .j 1054 to 1742 705 to 19   AAA   687/687
(100 %)
1 diff
(99.9 %id)
BQ952224 sciatic nerve .j 1056 to 1736 1 to 687       687/966
(71 %)
15 diff
(98.5 %id)
BQ005934 Chondrosarcoma, Left Pubic Bone .j 1061 to 1742 700 to 19   AAA   682/682
(100 %)
1 diff
(99.9 %id)
AA137142 uterus .j 1071 to 1320 1 to 251   fully sequenced,   251/251
(100 %)
2 diff
(99.3 %id)
BQ020392 Fibrosarcoma .j 1074 to 1742 687 to 19   AAA   669/669
(100 %)
0 diff
(100 %id)
AI498150 anaplastic oligodendroglioma, brain .j 1092 to 1743 652 to 2       651/653
(99 %)
0 diff
(100 %id)
CB529171 Aveolar Macrophage, lung .j 1100 to 1742 661 to 19   AAA   643/643
(100 %)
0 diff
(100 %id)
BF965743 Bone, osteosarcoma, cell line .j 1108 to 1743 1 to 635       635/650
(97 %)
7 diff
(99.0 %id)
TI_149285964   .j 1111 to 1741 777 to 148   AAA   630/790
(79 %)
42 diff
(94.7 %id)
AW168215 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j 1113 to 1743 626 to 1       626/627
(99 %)
9 diff
(98.6 %id)
BQ004633 Chondrosarcoma, Left Pelvis .j 1113 to 1742 648 to 19   AAA   630/630
(100 %)
1 diff
(99.9 %id)
BU594289 mixed (pool of 40 RNAs) .j 1120 to 1719 1 to 604   AAA   604/604
(100 %)
28 diff
(95.4 %id)
BE904299 epithelioid carcinoma, Pancreas .j 1154 to 1734 582 to 1     Submitted on the opposite strand 582/582
(100 %)
3 diff
(99.5 %id)
BM666236 eye, fetal eyes .j 1154 to 1742 607 to 19   AAA   589/589
(100 %)
1 diff
(99.9 %id)
AA420537   .j 1165 to 1694 1 to 531       531/531
(100 %)
3 diff
(99.5 %id)
AI831702 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .j 1168 to 1743 575 to 1       575/575
(100 %)
4 diff
(99.4 %id)
TI_149279809   .j 1169 to 1742 655 to 82   AAA   574/1199
(47 %)
8 diff
(99.4 %id)
AW079359 colon, moderately differentiated adenocarcinoma .j 1181 to 1741 566 to 1       566/566
(100 %)
5 diff
(99.2 %id)
BE855700 brain, glioblastoma (pooled) .j 1181 to 1742 563 to 1       563/563
(100 %)
1 diff
(99.9 %id)
AA721085 germinal center B cell .j 1183 to 1742 576 to 18   AAA   559/559
(100 %)
4 diff
(99.3 %id)
BQ267584 insulinoma, Pancreas .j 1184 to 1689 8 to 513   fully sequenced,   506/513
(98 %)
6 diff
(98.9 %id)
BU189503 melanotic melanoma, skin .j 1185 to 1741 24 to 580   AAA   557/580
(96 %)
12 diff
(98.0 %id)
CD522678 pooled .j 1191 to 1697 1 to 518       518/954
(54 %)
14 diff
(98.6 %id)
BE888487 leiomyosarcoma, uterus .j 1197 to 1743 1 to 546       546/1025
(53 %)
5 diff
(99.6 %id)
H60118 liver and spleen .j 1210 to 1265 405 to 463       422/482
(87 %)
21 diff
(95.7 %id)
BI964845 Islets of Langerhans, Pancreas .j 1213 to 1690 1 to 478       478/478
(100 %)
2 diff
(99.6 %id)
AA421698 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 1220 to 1743 524 to 1       524/524
(100 %)
1 diff
(99.9 %id)
AA743523 germinal center B cell .j 1221 to 1742 530 to 11   AAA   520/520
(100 %)
4 diff
(99.3 %id)
BQ272160 insulinoma, Pancreas .j 1223 to 1491 269 to 1   fully sequenced,   269/269
(100 %)
0 diff
(100 %id)
AI025231   .j 1227 to 1743 524 to 8       517/525
(98 %)
0 diff
(100 %id)
AI192924 lung .j 1232 to 1741 510 to 1       510/510
(100 %)
4 diff
(99.3 %id)
BG461306   .j 1235 to 1724 505 to 1     Submitted on the opposite strand 505/543
(93 %)
26 diff
(95.3 %id)
AA975238 pooled germ cell tumors .j 1237 to 1742 507 to 1       507/507
(100 %)
1 diff
(99.9 %id)
AW138745   .j 1243 to 1742 517 to 18   AAA   500/500
(100 %)
4 diff
(99.2 %id)
AA676627 liver and spleen .j 1244 to 1742 498 to 1       498/498
(100 %)
3 diff
(99.4 %id)
AI445040 colon, moderately-differentiated adenocarcinoma .j 1244 to 1742 499 to 1       499/499
(100 %)
2 diff
(99.6 %id)
AI858375 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 1245 to 1742 522 to 24   AAA   499/503
(99 %)
13 diff
(97.5 %id)
H11339.
matches multiple genes
whole brain .j 1250 to 1742 508 to 16   AAA also hits gene AGPS 493/496
(99 %)
5 diff
(99.0 %id)
BM663643 eye, Retina Foveal and Macular .j 1261 to 1742 499 to 18   fully sequenced, AAA   482/482
(100 %)
0 diff
(100 %id)
AA287821 germinal center B cell .j 1265 to 1742 477 to 1       477/477
(100 %)
4 diff
(99.2 %id)
AW183315 pooled .j 1265 to 1741 478 to 1       478/478
(100 %)
11 diff
(97.7 %id)
BP369057 testis .j 1265 to 1678 1 to 414   AAA   414/414
(100 %)
1 diff
(99.8 %id)
AA167048   .j 1268 to 1743 479 to 1     Submitted on the opposite strand 479/479
(100 %)
7 diff
(98.6 %id)
AA743896 Kidney .j 1269 to 1742 484 to 11   AAA   474/475
(99 %)
2 diff
(99.6 %id)
AA977876 2 pooled tumors (clear cell type), Kidney .j 1271 to 1743 475 to 4       472/475
(99 %)
0 diff
(100 %id)
AI493772 uterus .j 1273 to 1742 486 to 17   AAA   470/470
(100 %)
1 diff
(99.8 %id)
AA243818 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 1288 to 1691 1 to 404       404/404
(100 %)
0 diff
(100 %id)
AA137070 uterus .j 1290 to 1741 463 to 1   fully sequenced,   463/463
(100 %)
13 diff
(97.2 %id)
N39515 liver and spleen .j 1292 to 1741 452 to 1       452/452
(100 %)
6 diff
(98.7 %id)
AI341739   .j 1292 to 1743 455 to 4       452/455
(99 %)
0 diff
(100 %id)
AI969855 Prostate .j 1295 to 1742 448 to 1       448/448
(100 %)
1 diff
(99.8 %id)
AI805486 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j 1305 to 1742 453 to 17   AAA   437/439
(99 %)
7 diff
(98.5 %id)
DW465306 Liver .j 1308 to 1665 1 to 358       358/358
(100 %)
10 diff
(97.3 %id)
W49569 senescent fibroblast .j 1312 to 1743 441 to 5       437/441
(99 %)
0 diff
(100 %id)
CD677632 eye, Trabecular meshwork .j 1336 to 1741 1 to 406   AAA   406/406
(100 %)
1 diff
(99.8 %id)
BU678896 lung, Primary Lung Epithelial Cells .j 1337 to 1742 424 to 19   AAA   406/406
(100 %)
4 diff
(99.1 %id)
H94246 liver and spleen .j 1344 to 1743 408 to 3   fully sequenced,   406/408
(99 %)
0 diff
(100 %id)
AA181113   .j 1346 to 1700 355 to 1       355/355
(100 %)
0 diff
(100 %id)
AA723528 heart .j 1355 to 1743 390 to 1       390/390
(100 %)
20 diff
(94.9 %id)
BM971800 lung .j 1368 to 1741 392 to 19   AAA   374/374
(100 %)
1 diff
(99.8 %id)
AI274818 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .j 1376 to 1742 378 to 12   AAA   367/367
(100 %)
0 diff
(100 %id)
BG940324 blood .j 1387 to 1742 396 to 41   AAA   356/356
(100 %)
0 diff
(100 %id)
BI086372 cervix .j 1388 to 1742 1 to 355   AAA   355/355
(100 %)
0 diff
(100 %id)
AA376279 lung .j 1398 to 1742 345 to 1     Submitted on the opposite strand 345/345
(100 %)
0 diff
(100 %id)
AA807382 pooled germ cell tumors .j 1406 to 1742 337 to 1       337/337
(100 %)
0 diff
(100 %id)
BE049573 adenocarcinoma, Pancreas .j 1418 to 1741 331 to 8       324/331
(97 %)
0 diff
(100 %id)
AA173160   .j 1426 to 1742 155 to 471   AAA Submitted on the opposite strand 317/471
(67 %)
6 diff
(98.8 %id)
H59462 liver and spleen .j 1428 to 1736 312 to 1       312/316
(98 %)
3 diff
(99.1 %id)
H81643 eye, retina .j 1428 to 1687 261 to 1       261/266
(98 %)
1 diff
(99.7 %id)
BF061494 pooled .j 1449 to 1744 312 to 17   tiling clone, AAA   296/333
(88 %)
18 diff
(94.6 %id)
BU852012 mixed (pool of 40 RNAs) .j 1460 to 1742 1 to 280   AAA   280/280
(100 %)
3 diff
(99.0 %id)
BE538039 cervix .j 1473 to 1740 1 to 266       266/266
(100 %)
8 diff
(97.0 %id)
AI560597 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 1497 to 1742 266 to 21   AAA   246/246
(100 %)
3 diff
(98.8 %id)
AI216888   .j 1498 to 1743 248 to 3       246/248
(99 %)
0 diff
(100 %id)
N71297 liver and spleen .j 1507 to 1743 238 to 2       237/238
(99 %)
0 diff
(100 %id)
AW080571 colon, moderately differentiated adenocarcinoma .j 1538 to 1743 207 to 2       206/240
(85 %)
0 diff
(100 %id)
DW449043 Liver .j 1556 to 1739 17 to 200       184/205
(89 %)
2 diff
(99.1 %id)
DW461120 Liver .j 1556 to 1670 17 to 131       115/131
(87 %)
6 diff
(95.5 %id)
AW083156 colon, moderately differentiated adenocarcinoma .j 1595 to 1742 148 to 1       148/148
(100 %)
0 diff
(100 %id)
EH332943   .j 1604 to 1674 1 to 69       69/69
(100 %)
3 diff
(95.7 %id)
EH347762   .j 1608 to 1694 1 to 87       87/87
(100 %)
2 diff
(97.8 %id)
CT000639 T-Lymphocytes .k-u 1 to 633 1 to 635 exact tiling clone,   635/635
(100 %)
8 diff
(98.8 %id)
DB095634 testis .k-u 89 to 648 2 to 559   capped   558/558
(100 %)
5 diff
(99.2 %id)
DB097877 testis .k-u 89 to 665 2 to 576   capped   575/575
(100 %)
4 diff
(99.4 %id)
AW956743   .k-u 126 to 713 1 to 593       593/646
(91 %)
15 diff
(97.7 %id)
AA383193 testis .k-u 127 to 535 1 to 409       409/416
(98 %)
9 diff
(97.9 %id)
DB088890 testis .k-u 129 to 668 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
DB092256 testis .k-u 169 to 705 2 to 538   capped   537/537
(100 %)
3 diff
(99.5 %id)
DA245209 brain .k-u 350 to 934 2 to 586   capped   585/585
(100 %)
4 diff
(99.4 %id)
BM509591 Pancreas, Purified pancreatic islet .k-u 500 to 1131 1 to 632   tiling clone,   632/632
(100 %)
5 diff
(99.3 %id)
CK822540 Pancreas, Purified pancreatic islet .k-u 541 to 1111 1 to 571     Submitted on the opposite strand 571/571
(100 %)
1 diff
(99.9 %id)
N28231   .k-u 815 to 1086 272 to 1       272/272
(100 %)
0 diff
(100 %id)
CR994729 T-Lymphocytes .l 1 to 463 1 to 463   tiling clone,   463/469
(98 %)
1 diff
(99.8 %id)
CN264622 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .l 229 to 493 10 to 275       266/278
(95 %)
5 diff
(98.3 %id)
DA093064 cerebellum .l 232 to 806 2 to 575   capped   574/574
(100 %)
3 diff
(99.5 %id)
DA541648 lung .l 232 to 814 2 to 585   tiling clone, capped   584/584
(100 %)
1 diff
(99.9 %id)
DB145026 thymus .l 238 to 509 2 to 272   capped   271/271
(100 %)
3 diff
(98.9 %id)
BI601061 brain, hypothalamus .l 258 to 1051 6 to 805   tiling clone,   800/961
(83 %)
30 diff
(96.9 %id)
TI_45214432   .l 258 to 1051 89 to 888       800/1044
(76 %)
30 diff
(97.2 %id)
DR760201 embryonic stem .l 273 to 493 1 to 221       221/221
(100 %)
0 diff
(100 %id)
BG772791 testis .m-u 1 to 640 1 to 641 K2E tiling clone,   641/768
(83 %)
9 diff
(98.9 %id)
BM505197 Pancreas, Purified pancreatic islet .m-u 12 to 608 597 to 1       597/597
(100 %)
0 diff
(100 %id)
CK822541 Pancreas, Purified pancreatic islet .m-u 22 to 573 552 to 1     Submitted on the opposite strand 552/552
(100 %)
0 diff
(100 %id)
AA829870 germinal center B cell .m-u 133 to 616 486 to 3   tiling clone,   484/486
(99 %)
0 diff
(100 %id)
AW978983   .m-u 177 to 608 432 to 1     Submitted on the opposite strand 432/433
(99 %)
10 diff
(97.7 %id)
AA848090 germinal center B cell .m-u 187 to 554 367 to 1       367/367
(100 %)
7 diff
(98.1 %id)
AI827502 pooled .m-u 295 to 610 333 to 2       332/333
(99 %)
0 diff
(100 %id)
BX472309   .n 1 to 606 1 to 610 N5E I6H L7P L8C T9S ... tiling clone,   610/610
(100 %)
6 diff
(99.1 %id)
CN273880 embryonic stem cells, cell lines H1, H7, andH9 .o 1 to 596 1 to 596 exact tiling clone,   596/596
(100 %)
3 diff
(99.5 %id)
BM458650 lymph, lymphoma, cell line .p 1 to 595 26 to 620 G2V H4D tiling clone,   595/634
(93 %)
0 diff
(100 %id)
BG252797 adenocarcinoma, cell line, Liver .p 10 to 595 1 to 612       591/849
(69 %)
49 diff
(94.3 %id)
DA820737 pericardium .q-u 1 to 498 2 to 499 H18R tiling clone, capped   498/498
(100 %)
2 diff
(99.6 %id)
DA106271 cerebellum .r 1 to 482 2 to 483   tiling clone, capped   482/482
(100 %)
2 diff
(99.6 %id)
AV702908 adrenal gland Gene TAF9, variant not shown         Suspected internal deletion, this clone was ignored    
AV704013 adrenal gland Gene TAF9, variant not shown         Suspected internal deletion, this clone was ignored    
AF110777 adrenal gland Gene TAF9, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AW814653 stomach Gene TAF9, variant not shown              
BC033320 testis Gene TAF9, variant not shown       available from MGC, AAA This clone was ignored    
AV717548   Gene TAF9, variant not shown         Suspected internal deletion, this clone was ignored    
AV684243 hepatocellular carcinoma Gene TAF9, variant not shown         Suspected internal deletion, this clone was ignored    
AV694027 hepatocellular carcinoma Gene TAF9, variant not shown         Suspected internal deletion, this clone was ignored    
AV697323 hepatocellular carcinoma Gene TAF9, variant not shown         Suspected internal deletion, this clone was ignored    
AV725488 hypothalamus Gene TAF9, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AV727986 hypothalamus Gene TAF9, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AV729127 hypothalamus Gene TAF9, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AV729103 hypothalamus Gene TAF9, variant not shown       AAA Suspected internal deletion, this clone was ignored    
N95197 lung Gene TAF9, variant not shown         Suspected internal deletion, this clone was ignored    
W24598 lung Gene TAF9, variant not shown         Suspected internal deletion, this clone was ignored    
BE219765 carcinoid, lung Gene TAF9, variant not shown         Submitted on the opposite strand    
BM994191 lung, Metastatic Chondrosarcoma Gene TAF9, variant not shown       AAA      
DB017270 esophageal, tumor tissue Gene TAF9, variant not shown       capped This clone was ignored    
DB088032 testis Gene TAF9, variant not shown       capped      
DB341246 testis Gene TAF9, variant not shown              
DB132615 thymus Gene TAF9, variant not shown       capped      
DB344737 thymus Gene TAF9, variant not shown              
DB134857 thymus Gene TAF9, variant not shown       capped      
DB138383 thymus Gene TAF9, variant not shown       capped      
DB143535 thymus Gene TAF9, variant not shown       capped      
DB150826 thymus Gene TAF9, variant not shown       capped      
CB242953 Human Lung Epithelial cells, lung Gene TAF9, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a-u, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l, .m-u, .n, .o, .p, .q-u, .r Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI